Six Australian startup health innovators awarded $13.5 million through CUREator+ to accelerate breakthrough medical therapies and technologies.
CUREator+ granted thirteen point five million dollars in non-dilutive funding to six Australian health tech startups to support commercialisation of medical innovations.